# Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure

Study · id `cardio:ct-nct02797340` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02797340](<https://clinicaltrials.gov/study/NCT02797340>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02797340

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

## Technical summary

Registry record NCT02797340. Allocation not applicable; no masking; primary purpose other. Start 2016-01-11 (actual); primary completion 2018-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT02797340, source copy `cardio:ctgov-nct02797340-2018-04-20`, retrieved 2026-10-26)
- Started: 2016-01-11 (actual) (ClinicalTrials.gov record NCT02797340, source copy `cardio:ctgov-nct02797340-2018-04-20`, retrieved 2026-10-26)
- Primary completion: 2018-04-30 (anticipated) (ClinicalTrials.gov record NCT02797340, source copy `cardio:ctgov-nct02797340-2018-04-20`, retrieved 2026-10-26)
- Completion: 2018-04-30 (anticipated) (ClinicalTrials.gov record NCT02797340, source copy `cardio:ctgov-nct02797340-2018-04-20`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02797340, source copy `cardio:ctgov-nct02797340-2018-04-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02797340-2018-04-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure
- Acronym: MetKin
- Condition: Heart Failure, Systolic
- Intervention (Other): Blood draws and urine samples for metformin concentration measurements
- Intervention (Drug): Metformin
- Lead sponsor: Aarhus University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry lists this organization as the lead sponsor: Aarhus University Hospital (`cardio:org-aarhus-university-hospital`)

## Provenance

Content hash: 032dd3c1cdf5072326a1c851dece64c63b71cb62db60ff9c3845c85122564b58
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
